{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:48:19Z","timestamp":1781880499218,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27876-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:46:55Z","timestamp":1766072815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial)"],"prefix":"10.1038","volume":"15","author":[{"given":"Saran","family":"Sukkamolsantiporn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phubordee","family":"Bongkotvirawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonthorn","family":"Chonprasertsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bubpha","family":"Pornthisarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sith","family":"Siramolpiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patommatat","family":"Bhanthumkomol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navapan","family":"Issariyakulkarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornpen","family":"Gamnarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Wongcha-Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuda","family":"Aumpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virunpat","family":"Vilaichone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phornphan","family":"Sornchuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varocha","family":"Mahachai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Miftahussurur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peerapong","family":"Kitipawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratha-korn","family":"Vilaichone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"27876_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","volume":"150","author":"M Amieva","year":"2016","unstructured":"Amieva, M. & Peek, R. M. Jr. Pathobiology of Helicobacter pylori-Induced gastric cancer. Gastroenterology 150, 64\u201378. https:\/\/doi.org\/10.1053\/j.gastro.2015.09.004 (2016).","journal-title":"Gastroenterology"},{"key":"27876_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.tim.2023.04.001","volume":"31","author":"A Nabavi-Rad","year":"2023","unstructured":"Nabavi-Rad, A. et al. The interaction between autophagy, Helicobacter pylori, and gut microbiota in gastric carcinogenesis. Trends Microbiol. 31, 1024\u20131043. https:\/\/doi.org\/10.1016\/j.tim.2023.04.001 (2023).","journal-title":"Trends Microbiol."},{"key":"27876_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4251\/wjgo.v7.i12.455","volume":"7","author":"HJ Ahn","year":"2015","unstructured":"Ahn, H. J. & Lee, D. S. Helicobacter pylori in gastric carcinogenesis. World J. Gastrointest. Oncol. 7, 455\u2013465. https:\/\/doi.org\/10.4251\/wjgo.v7.i12.455 (2015).","journal-title":"World J. Gastrointest. Oncol."},{"key":"27876_CR4","doi-asserted-by":"publisher","unstructured":"Chen, Y. C. et al. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022. Gastroenterology 166, 605\u2013619 https:\/\/doi.org\/10.1053\/j.gastro.2023.12.022 (2024).","DOI":"10.1053\/j.gastro.2023.12.022"},{"key":"27876_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 8, 553\u2013564. https:\/\/doi.org\/10.1016\/s2468-1253(23)00070-5 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"27876_CR6","doi-asserted-by":"publisher","unstructured":"Bongkotvirawan, P. et al. Sa1375 Epidemiology and antibiotic resistance pattern of helicobacter pylori infection in south east asia countries: a systematic review with meta-analysis. Gastroenterology 166 (S-435). https:\/\/doi.org\/10.1016\/S0016-5085(24)01477-X (2024).","DOI":"10.1016\/S0016-5085(24)01477-X"},{"key":"27876_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-023-08504-5","volume":"23","author":"M Shirani","year":"2023","unstructured":"Shirani, M. et al. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC Infect. Dis. 23, 543. https:\/\/doi.org\/10.1186\/s12879-023-08504-5 (2023).","journal-title":"BMC Infect. Dis."},{"key":"27876_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"27876_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.14309\/ajg.0000000000002600","volume":"119","author":"L Bujanda","year":"2024","unstructured":"Bujanda, L. et al. Effectiveness of Helicobacter pylori treatments according to antibiotic resistance. Am. J. Gastroenterol. 119, 646\u2013654. https:\/\/doi.org\/10.14309\/ajg.0000000000002600 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"27876_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s2468-1253(23)00281-9","volume":"9","author":"TC Hong","year":"2024","unstructured":"Hong, T. C. et al. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 9, 56\u201367. https:\/\/doi.org\/10.1016\/s2468-1253(23)00281-9 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"27876_CR11","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","volume":"119","author":"WD Chey","year":"2024","unstructured":"Chey, W. D. et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 119, 1730\u20131753. https:\/\/doi.org\/10.14309\/ajg.0000000000002968 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"27876_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ueg2.12569","volume":"12","author":"JM Huguet","year":"2024","unstructured":"Huguet, J. M. et al. Role of compliance in Helicobacter pylori eradication treatment: results of the European registry on H. pylori management. United Eur. Gastroenterol. J. 12, 691\u2013704. https:\/\/doi.org\/10.1002\/ueg2.12569 (2024).","journal-title":"United Eur. Gastroenterol. J."},{"key":"27876_CR13","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3748\/wjg.v25.i34.5097","volume":"25","author":"E Ierardi","year":"2019","unstructured":"Ierardi, E. et al. Optimizing proton pump inhibitors in Helicobacter pylori treatment: old and new tricks to improve effectiveness. World J. Gastroenterol. 25, 5097\u20135104. https:\/\/doi.org\/10.3748\/wjg.v25.i34.5097 (2019).","journal-title":"World J. Gastroenterol."},{"key":"27876_CR14","doi-asserted-by":"publisher","unstructured":"Ke, H. et al. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy. Helicobacter 26 (e12768). https:\/\/doi.org\/10.1111\/hel.12768 (2021).","DOI":"10.1111\/hel.12768"},{"key":"27876_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel, A., Laine, L., Moayyedi, P. & Wu, J. A. G. A. Clinical practice update on integrating Potassium-Competitive acid blockers into clinical practice: expert review. Gastroenterology 167, 1228\u20131238. https:\/\/doi.org\/10.1053\/j.gastro.2024.06.038 (2024).","journal-title":"Gastroenterology"},{"key":"27876_CR16","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","volume":"163","author":"WD Chey","year":"2022","unstructured":"Chey, W. D. et al. Vonoprazan triple and dual therapy for Helicobacter pylori infection in the united States and europe: randomized clinical trial. Gastroenterology 163, 608\u2013619. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.055 (2022).","journal-title":"Gastroenterology"},{"key":"27876_CR17","doi-asserted-by":"publisher","first-page":"e13019","DOI":"10.1111\/hel.13019","volume":"28","author":"S Ratana-Amornpin","year":"2023","unstructured":"Ratana-Amornpin, S. et al. Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand May be more similar to the US than Japan. Helicobacter 28, e13019. https:\/\/doi.org\/10.1111\/hel.13019 (2023).","journal-title":"Helicobacter"},{"key":"27876_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5056\/jnm18081","volume":"25","author":"R Pittayanon","year":"2019","unstructured":"Pittayanon, R. et al. Thail. Dyspepsia Guidelines: 2018 J Neurogastroenterol Motil 25, 15\u201326 https:\/\/doi.org\/10.5056\/jnm18081 (2019).","journal-title":"Thail. Dyspepsia Guidelines: 2018 J Neurogastroenterol Motil"},{"key":"27876_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/apt.15641","volume":"51","author":"T Takeuchi","year":"2020","unstructured":"Takeuchi, T. et al. Randomised trial of acid Inhibition by Vonoprazan 10\/20\u00a0mg once daily vs Rabeprazole 10\/20\u00a0mg twice daily in healthy Japanese volunteers (SAMURAI pH study). Aliment. Pharmacol. Ther. 51, 534\u2013543. https:\/\/doi.org\/10.1111\/apt.15641 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"27876_CR20","doi-asserted-by":"publisher","first-page":"9045","DOI":"10.1038\/s41598-018-27482-2","volume":"8","author":"HY Gan","year":"2018","unstructured":"Gan, H. Y. et al. Efficacy of two different dosages of Levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial. Sci. Rep. 8, 9045. https:\/\/doi.org\/10.1038\/s41598-018-27482-2 (2018).","journal-title":"Sci. Rep."},{"key":"27876_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner, P. et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut https:\/\/doi.org\/10.1136\/gutjnl-2022-327745 (2022).","journal-title":"Gut"},{"key":"27876_CR22","doi-asserted-by":"publisher","first-page":"8986","DOI":"10.1038\/s41598-024-59621-3","volume":"14","author":"N Tungtrongchitr","year":"2024","unstructured":"Tungtrongchitr, N. et al. Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and Levofloxacin resistance: a prospective randomized study (VQ-HP trial). Sci. Rep. 14, 8986. https:\/\/doi.org\/10.1038\/s41598-024-59621-3 (2024).","journal-title":"Sci. Rep."},{"key":"27876_CR23","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.2147\/ijgm.S427450","volume":"16","author":"F Lu","year":"2023","unstructured":"Lu, F., Xu, W., Shi, X., Yu, H. & Qi, X. 14-Day Vonoprazan-Based bismuth quadruple therapy for Treatment-Na\u00efve patients with Helicobacter pylori infection: A retrospective comparative study. Int. J. Gen. Med. 16, 4279\u20134281. https:\/\/doi.org\/10.2147\/ijgm.S427450 (2023).","journal-title":"Int. J. Gen. Med."},{"key":"27876_CR24","doi-asserted-by":"publisher","first-page":"e12940","DOI":"10.1111\/hel.12940","volume":"28","author":"L Lu","year":"2023","unstructured":"Lu, L. et al. Quadruple therapy with Vonoprazan 20\u00a0mg daily as a first-line treatment for Helicobacter pylori infection: A single-center, open-label, noninferiority, randomized controlled trial. Helicobacter 28, e12940. https:\/\/doi.org\/10.1111\/hel.12940 (2023).","journal-title":"Helicobacter"},{"key":"27876_CR25","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3748\/wjg.15.1528","volume":"15","author":"Y Yin","year":"2009","unstructured":"Yin, Y., He, L. H. & Zhang, J. Z. Successful isolation of Helicobacter pylori after prolonged incubation from a patient with failed eradication therapy. World J. Gastroenterol. 15, 1528\u20131529. https:\/\/doi.org\/10.3748\/wjg.15.1528 (2009).","journal-title":"World J. Gastroenterol."},{"key":"27876_CR26","doi-asserted-by":"publisher","unstructured":"Sukri, A., Lopes, B. S. & Hanafiah, A. The emergence of Multidrug-Resistant Helicobacter pylori in Southeast asia: A systematic review on the trends and intervention strategies using antimicrobial peptides. Antibiot. (Basel). 10 https:\/\/doi.org\/10.3390\/antibiotics10091061 (2021).","DOI":"10.3390\/antibiotics10091061"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27876-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:46:55Z","timestamp":1766072815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27876-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27876"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27876-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44105"}}